- BBIO +0.18%
Search results
- 27.88Add to watchlist+0.05 (+0.18%)As of Mon. May 6, 2024 11:30 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open28.13High28.28Low27.55
- Mkt Cap5.22BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close27.8352 Wk. Low12.7552 Wk. High44.32
Top storiesWhat You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade TodayYahoo Finance · 2 days ago- BBIO +0.18%
BridgeBio Pharma First Quarter 2024 Earnings: Beats ExpectationsYahoo Finance · 3 days ago- BBIO +0.18%
Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should KnowYahoo Finance · 2 weeks agoRelated stocks
Find the latest BridgeBio Pharma, Inc. (BBIO) stock quote, history, news and other vital information to help you with your stock trading and investing.
BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
Get the latest BridgeBio Pharma Inc (BBIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
6 days ago · BBIO | Complete BridgeBio Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest BridgeBio Pharma, Inc. (BBIO) stock news and headlines to help you in your trading and investing decisions.
Mar 20, 2024 · BridgeBio Pharma Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials.
4 days ago · A high-level overview of BridgeBio Pharma, Inc. (BBIO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.